Endpoint definition
↥| Name | CML |
|---|---|
| Long name | Chronic myeloid leukaemia [CML], BCR/ABL-positive |
| Hospital Discharge registry | ICD-10: C921 |
| Cause of Death registry | ICD-10: C921 |
| First defined in version | DF2, additional |
| Name | CML |
|---|---|
| Long name | Chronic myeloid leukaemia [CML], BCR/ABL-positive |
| Hospital Discharge registry | ICD-10: C921 |
| Cause of Death registry | ICD-10: C921 |
| First defined in version | DF2, additional |
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 111 | 55 | 56 |
| Unadjusted prevalence (%) | 0.05 | 0.04 | 0.06 |
| Mean age at first event (years) | 58.04 | 56.79 | 59.27 |
| Case fatality at 5-years (%) | 12.61 | 12.73 | 12.50 |
| All | Female | Male | |
|---|---|---|---|
| Median nb. of events per indiv. | 12.0 | 11.0 | 14.0 |
| Recurrence at 6 months (%) | 82.88 | 76.36 | 89.29 |
before Chronic myeloid leukaemia [CML], BCR/ABL-positive
after Chronic myeloid leukaemia [CML], BCR/ABL-positive
Loading survival analyses plot…
Loading survival analyses table…